Clinical Trials Browser

Phase 1/2 × futuximab × Gastrointestinal × Clear all

NCT02568046 2019-03-26

Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients

Phase 1/2 Terminated

10 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT01117428 2018-10-15

Sym004 in Patients With Advanced Solid Tumors

Phase 1/2 Completed

111 enrolled 18 charts

Gastrointestinal

Colorectal Neoplasms